STRAMUCIN CREAM

국가: 캐나다

언어: 영어

출처: Health Canada

유효 성분:

MUPIROCIN (MUPIROCIN CALCIUM)

제공처:

GLENMARK PHARMACEUTICALS CANADA INC.

ATC 코드:

D06AX09

INN (국제 이름):

MUPIROCIN

복용량:

2%

약제 형태:

CREAM

구성:

MUPIROCIN (MUPIROCIN CALCIUM) 2%

관리 경로:

TOPICAL

패키지 단위:

15G

처방전 유형:

OTC

치료 영역:

ANTIBIOTICS

제품 요약:

Active ingredient group (AIG) number: 0117081001; AHFS:

승인 상태:

APPROVED

승인 날짜:

2018-11-29

제품 특성 요약

_Product Monograph – STRAMUCIN_
TM
_ (Mupirocin Cream USP, 2% w/w) _
_Date: November 21, 2018 _
_Page 1 of 20_
PRODUCT MONOGRAPH
INCLUDING PATIENT MEDICATION INFORMATION
STRAMUCIN
TM
Mupirocin Cream USP
2% (w/w) mupirocin (as mupirocin calcium)
Topical Antibiotic
Glenmark Pharmaceuticals Canada Inc.
500 King St W, 3
rd
Floor
Toronto, ON
M5V 1L9
Date of Initial Approval: TBD
Date of Preparation: November 21,
2018
Submission Control No: 209943
_ _
_Product Monograph – STRAMUCIN_
TM
_ (Mupirocin Cream USP, 2% w/w) _
_Date: November 21, 2018 _
_Page 2 of 20 _
TABLE OF CONTENTS
TABLE OF CONTENTS ..............................................................................................................2
PART I: HEALTH PROFESSIONAL INFORMATION ............................................................4
1
INDICATIONS
....................................................................................................................4
1.1
Pediatrics
....................................................................................................................4
1.2
Geriatrics
....................................................................................................................4
2
CONTRAINDICATIONS ..................................................................................................4
3
SERIOUS WARNINGS AND PRECAUTIONS BOX ..................................................4
4
DOSAGE AND ADMINISTRATION ...............................................................................4
4.1
Dosing Considerations
...............................................................................................4
4.2
Recommended Dose and Dosage Adjustment
...........................................................5
4.3
Missed Dose
...............................................................................................................5
5
OVERDOSAGE .................................................................................................................5
6
DOSAGE FORMS, STRENGTHS, COM